Search research articles
Contact Us
Filters
Showing results (81-90 of 102) with videos related to
Page
of 11
Sort By:
Anales De Medicina Interna (Madrid, Spain : 1984)
|
August 16, 2001
[Generalized convulsive status epilepticus: analysis apropos of 57 cases]
E Miñambres García, X Antolínez Eizaguirre, J Infante Ceberio, et al.
European Journal of Neurology
|
February 21, 2008
Inflammation-related genes and the risk of Parkinson's disease: a multilocus approach
J Infante, I García-Gorostiaga, P Sánchez-Juan, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
February 27, 2008
Aromatase and interleukin-10 genetic variants interactively modulate Alzheimer's disease risk
O Combarros, P Sánchez-Juan, J A Riancho, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
December 19, 2020
EGFR-targeting antitumor therapy: Neuregulins or antibodies?
Isabel de Lavera, Patrick J Merkling, José M Oliva, et al.
Laboratory Animal Science
|
March 25, 1999
Absence of a significant mixed lymphocyte reaction in a marsupial (Monodelphis domestica)
W H Stone, D A Brunn, E B Foster, et al.
European Journal of Neurology
|
December 31, 2009
Synergistic effect of two oxidative stress-related genes (heme oxygenase-1 and GSK3β) on the risk of Parkinson's disease
J Infante, I García-Gorostiaga, P Sánchez-Juan, et al.
Journal of Neuroscience Research
|
August 15, 1996
Evidence against chronic antigen-specific T lymphocyte activation in myasthenia gravis
A J Infante, P D Infante, C E Jackson, et al.
The Journal of Pediatrics
|
November 20, 1998
The clinical spectrum in a large kindred with autoimmune lymphoproliferative syndrome caused by a Fas mutation that impairs lymphocyte apoptosis
A J Infante, H A Britton, T DeNapoli, et al.
European Journal of Neurology
|
February 13, 2013
Reduced serum progranulin level might be associated with Parkinson's disease risk
I Mateo, I González-Aramburu, A Pozueta, et al.
Oncogene
|
August 6, 2008
PDGFR-A is a therapeutic target in alveolar rhabdomyosarcoma
E Taniguchi, K Nishijo, A T McCleish, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 102) with videos related to
Sort By:
Page
of 11
Anales De Medicina Interna (Madrid, Spain : 1984)
|
August 16, 2001
[Generalized convulsive status epilepticus: analysis apropos of 57 cases]
E Miñambres García, X Antolínez Eizaguirre, J Infante Ceberio, et al.
European Journal of Neurology
|
February 21, 2008
Inflammation-related genes and the risk of Parkinson's disease: a multilocus approach
J Infante, I García-Gorostiaga, P Sánchez-Juan, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
February 27, 2008
Aromatase and interleukin-10 genetic variants interactively modulate Alzheimer's disease risk
O Combarros, P Sánchez-Juan, J A Riancho, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
December 19, 2020
EGFR-targeting antitumor therapy: Neuregulins or antibodies?
Isabel de Lavera, Patrick J Merkling, José M Oliva, et al.
Laboratory Animal Science
|
March 25, 1999
Absence of a significant mixed lymphocyte reaction in a marsupial (Monodelphis domestica)
W H Stone, D A Brunn, E B Foster, et al.
European Journal of Neurology
|
December 31, 2009
Synergistic effect of two oxidative stress-related genes (heme oxygenase-1 and GSK3β) on the risk of Parkinson's disease
J Infante, I García-Gorostiaga, P Sánchez-Juan, et al.
Journal of Neuroscience Research
|
August 15, 1996
Evidence against chronic antigen-specific T lymphocyte activation in myasthenia gravis
A J Infante, P D Infante, C E Jackson, et al.
The Journal of Pediatrics
|
November 20, 1998
The clinical spectrum in a large kindred with autoimmune lymphoproliferative syndrome caused by a Fas mutation that impairs lymphocyte apoptosis
A J Infante, H A Britton, T DeNapoli, et al.
European Journal of Neurology
|
February 13, 2013
Reduced serum progranulin level might be associated with Parkinson's disease risk
I Mateo, I González-Aramburu, A Pozueta, et al.
Oncogene
|
August 6, 2008
PDGFR-A is a therapeutic target in alveolar rhabdomyosarcoma
E Taniguchi, K Nishijo, A T McCleish, et al.
Page
of 11